E2-EN/DHPA is used in combination as a once-monthly combined injectable contraceptive to prevent pregnancy in women in Latin America and Hong Kong. E2-EN/DHPA has been said to be used by "travestis" (a term for transgender women in some cultures, especially in South America) as a means of feminizing hormone therapy as well. Available forms The following forms of E2-EN/DHPA are or have been available for use: * E2-EN 10 mg and DHPA 150 mg (brand names Perlutal, Topasel, many others) * E2-EN 5 mg and DHPA 75 mg (brand names Anafertin, Patector NF, Yectames) * E2-EN 10 mg and DHPA 120 mg (brand names Unalmes, Yectuna) * E2-EN 10 mg and DHPA 75 mg (brand name Ova Repos; discontinued) A 6 mg E2-EN and 90 mg DHPA formulation was also studied, but was never marketed. The combination of E2-EN and DHPA has also been studied at other doses ranging from 5 to 50 mg E2-EN and 75 to 200 mg DHPA.
Estradiol enantate/algestone acetophenide
Estradiol benzoate butyrate/algestone acetophenide
Estradiol undecylate/norethisterone enanthate
Estradiol pivalate/progesterone
Elagolix/estradiol/norethindrone acetate
Estradiol benzoate/estradiol dienanthate/testosterone enanthate benzilic acid hydrazone
Estradiol benzoate/estradiol phenylpropionate
Estradiol cypionate/testosterone cypionate